A Phase II Trial of High-Dose Mitoxantrone, Carboplatin, and Cyclophosphamide with Autologous Bone Marrow Rescue for Recurrent Epithelial Ovarian Carcinoma: Analysis of Risk Factors for Clinical Outcome
- 1 June 1995
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 57 (3) , 278-285
- https://doi.org/10.1006/gyno.1995.1143
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: